EssilorLuxottica heir weighs $8.3M takeover of Italian newspaper
We haven't written up this one. Seeking Alpha News has the full story — the link below goes straight to it.
More in Finance & Markets
Should You Buy Bristol Myers Squibb While It Trades Below 10 Times Forward Earnings?
Bristol Myers Squibb is facing a sizable patent cliff, but that's not unusual in the pharma sector.
- Bristol Myers Squibb trades at 9.7 times forward earnings, below the five-year average
- Competitor Eli Lilly has a much higher forward earnings ratio of 35.6 times
- Bristol Myers Squibb's lower valuation stems from upcoming patent expirations on Opdivo and Eliquis
Audi CEO Gernot Döllner appears on stage with Trump at a Republican campaign rally to announce a new car factory in Georgia
Trump said Audi would commit $4.2 billion in nearby Macon to begin construction on a plant that will produce 200,000 cars a year.
Crypto market unfazed by protests
Protests spreading across Europe have had limited impact on Bitcoin thus far, but if the unrest turns into a wider European bond or equity sell-off, it could weigh on risk appetite across assets…
Bayern survive late scare to beat Freiburg 3-1
The Bundesliga champions preserved their unbeaten start but had to withstand late pressure from Freiburg, who pushed for an equaliser.
American Express profits rise; company plans to cut workforce by 5%
AgenciesAmerican Express profits rose sharply in the third quarter as it transitioned the vast majority of its members to a new, higher-fee Platinum Card while its well-to-do custo...